Sixty-seven patients (mean age 82 years) with urinary tract infection were treated with either Augmentin or amoxycillin in a double-blind randomised trial. Of the 52 patients who completed 5 days treatment, 21/24 (87.5%) responded to Augmentin but only 12/28 (43%) responded to amoxycillin. Five of eight patients who had failed to respond to amoxycillin responded to Augmentin.